Literature DB >> 22216906

Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions.

Cécile Denis1, Mélina Fatséas, Virginie Beltran, Claire Bonnet, Stéphane Picard, Isabelle Combourieu, Jean-Pierre Daulouède, Marc Auriacombe.   

Abstract

The study examined the validity of 1848 self-reported uses of drugs determined within an Addiction Severity Index interview in comparison with urinalysis results among drug-dependent subjects undergoing treatment in outpatient clinics (Aquitaine area, southwest France, 1994-2005). Agreement and kappa statistics were calculated for each substance. Factors associated with agreement were defined using a multivariate analysis. The conditional kappa coefficients were excellent for all substances assessed. The accuracy between self-reports and urinalysis results was influenced by factors that only slightly affected conditional kappa coefficients. Clients did not underreport their substance use in naturalistic clinical assessment conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22216906     DOI: 10.3109/10826084.2011.640732

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  25 in total

1.  Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Authors:  Mary-Lynn Brecht; Diane Herbeck
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

2.  A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.

Authors:  Brent A Moore; Frank D Buono; Daniel P Lloyd; Destiny M B Printz; David A Fiellin; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2018-11-24

3.  Comparison Between Urinalysis Results and Self-Reported Heroin Use Among Patients Undergoing Methadone Maintenance Treatment in China.

Authors:  Li Li; Li-Jung Liang; Chunqing Lin; Nan Feng; Zunyou Wu
Journal:  Subst Use Misuse       Date:  2017-03-27       Impact factor: 2.164

4.  Multicentre study for validation of the French addictovigilance network reports assessment tool.

Authors:  Caroline Victorri-Vigneau; Jean Benoit Hardouin; Morgane Rousselet; Marie Gerardin; Marylène Guerlais; Morgane Guillou; Marie Bronnec; Véronique Sébille; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

5.  Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017.

Authors:  Kirsten Elin Smith; Adrian Archuleta; Michele Staton; Erin Winston
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-03       Impact factor: 3.829

6.  Fathers for Change for Substance Use and Intimate Partner Violence: Initial Community Pilot.

Authors:  Carla Smith Stover
Journal:  Fam Process       Date:  2015-02-12

7.  Polysubstance Use Patterns among Justice-Involved Individuals Who Use Opioids.

Authors:  Amanda M Bunting; Carrie Oser; Michele Staton; Hannah Knudsen
Journal:  Subst Use Misuse       Date:  2020-07-20       Impact factor: 2.164

8.  The Relationship of Reflective Functioning to Parent Child Interactions in a Sample of Fathers With Concurrent Intimate Partner Violence Perpetration and Substance Abuse Problems.

Authors:  Carla Smith Stover; Erica E Coates
Journal:  J Fam Violence       Date:  2015-09-10

9.  Hostility and substance use in relation to intimate partner violence and parenting among fathers.

Authors:  Carla Smith Stover; Andrew Kiselica
Journal:  Aggress Behav       Date:  2014-07-10       Impact factor: 2.917

10.  Measuring Current Drug Use in Female Sex Workers and Their Noncommercial Male Partners in Mexico: Concordance Between Data Collected From Surveys Versus Semi-Structured Interviews.

Authors:  Lawrence A Palinkas; Angela Robertson Bazzi; Jennifer L Syvertsen; Monica D Ulibarri; Daniel Hernandez; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee
Journal:  Subst Use Misuse       Date:  2015-12-18       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.